Effects of total coronary artery occlusion on vascular endothieial growth factor and transforming growth factor beta

Tsung-Hsien Lin1, Hsueh-Wei Yen, Ho-Ming Su

  • 1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Chun-Ho Memorial Hospital, Taiwan.

Insights

Vascular endothelial growth factor (VEGF) levels in the coronary sinus were higher in coronary artery disease patients with total occlusions. This suggests VEGF plays a role in angiogenesis development in these patients.

Area of Science:

  • Cardiovascular Biology
  • Angiogenesis Research
  • Biomarker Discovery

Background:

  • Vascular endothelial growth factor (VEGF) and transforming growth factor beta 1 (TGF-beta1) are key regulators of angiogenesis.
  • Coronary artery disease (CAD) involves complex vascular remodeling processes.

Purpose of the Study:

  • To investigate if VEGF and TGF-beta1 concentrations differ in the coronary sinus (CS) and right atrium (RA) between CAD patients with total versus partial coronary occlusions.
  • To explore the potential role of these growth factors in angiogenesis within the context of CAD severity.

Main Methods:

  • Blood samples were collected from the CS and RA of 47 CAD patients undergoing coronary angiography.
  • Concentrations of VEGF and TGF-beta1 were measured and compared between patients with total occlusions and those with non-total occlusions.
  • Coronary angiographic findings were interpreted independently of the growth factor data.

Main Results:

  • VEGF concentrations were significantly higher in the CS compared to the RA in all evaluated CAD patients (p=0.005).
  • Patients with total coronary occlusions exhibited significantly higher VEGF concentrations in the CS than those with non-total occlusions (p=0.037).
  • No statistically significant differences in TGF-beta1 concentrations were observed between the groups.

Conclusions:

  • Elevated VEGF levels in the coronary sinus of patients with total coronary occlusions suggest a role for VEGF in angiogenesis associated with severe CAD.
  • VEGF may serve as a potential biomarker for angiogenesis in advanced coronary artery disease.
  • Further research is warranted to elucidate the precise mechanisms of VEGF in CAD progression.